Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a cash flow conversion efficiency ratio of -0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-15.07 Million ≈ $-2.21 Million USD) by net assets (CN¥1.74 Billion ≈ $254.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Jiangsu Lianhuan Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
Jiangsu Lianhuan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Jiangsu Lianhuan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangsu Lianhuan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Lianhuan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
-0.026x |
|
Zhejiang Shengyang Science
SHG:603703
|
0.010x |
|
Latitude Group Holdings Ltd
AU:LFS
|
-0.057x |
|
Patrizia AG
XETRA:PAT
|
0.038x |
|
Zheshang Development Group Co Ltd
SHE:000906
|
-0.164x |
|
Jiujiang Shanshui Technology Co.Ltd
SHE:301190
|
-0.002x |
|
Sinovac Biotech Ltd
NASDAQ:SVA
|
0.023x |
|
China Building Material
SHG:603060
|
0.043x |
Annual Cash Flow Conversion Efficiency for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2002 to 2024. View 600513 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.58 Billion ≈ $230.80 Million |
CN¥10.77 Million ≈ $1.58 Million |
0.007x | -93.56% |
| 2023-12-31 | CN¥1.52 Billion ≈ $222.03 Million |
CN¥160.70 Million ≈ $23.52 Million |
0.106x | +17.35% |
| 2022-12-31 | CN¥1.41 Billion ≈ $206.87 Million |
CN¥127.59 Million ≈ $18.67 Million |
0.090x | -16.44% |
| 2021-12-31 | CN¥1.28 Billion ≈ $187.44 Million |
CN¥138.34 Million ≈ $20.24 Million |
0.108x | +38.86% |
| 2020-12-31 | CN¥1.18 Billion ≈ $172.97 Million |
CN¥91.94 Million ≈ $13.45 Million |
0.078x | +954.26% |
| 2019-12-31 | CN¥1.08 Billion ≈ $158.63 Million |
CN¥-9.87 Million ≈ $-1.44 Million |
-0.009x | +90.63% |
| 2018-12-31 | CN¥946.61 Million ≈ $138.52 Million |
CN¥-92.00 Million ≈ $-13.46 Million |
-0.097x | -2447.48% |
| 2017-12-31 | CN¥878.23 Million ≈ $128.51 Million |
CN¥3.64 Million ≈ $532.06K |
0.004x | -95.13% |
| 2016-12-31 | CN¥827.25 Million ≈ $121.05 Million |
CN¥70.28 Million ≈ $10.28 Million |
0.085x | +5.99% |
| 2015-12-31 | CN¥774.88 Million ≈ $113.39 Million |
CN¥62.12 Million ≈ $9.09 Million |
0.080x | -49.91% |
| 2014-12-31 | CN¥434.25 Million ≈ $63.54 Million |
CN¥69.50 Million ≈ $10.17 Million |
0.160x | +73.13% |
| 2013-12-31 | CN¥402.11 Million ≈ $58.84 Million |
CN¥37.17 Million ≈ $5.44 Million |
0.092x | +91.22% |
| 2012-12-31 | CN¥350.42 Million ≈ $51.28 Million |
CN¥16.94 Million ≈ $2.48 Million |
0.048x | -34.00% |
| 2011-12-31 | CN¥327.61 Million ≈ $47.94 Million |
CN¥24.00 Million ≈ $3.51 Million |
0.073x | +168.56% |
| 2010-12-31 | CN¥308.95 Million ≈ $45.21 Million |
CN¥8.43 Million ≈ $1.23 Million |
0.027x | -42.05% |
| 2009-12-31 | CN¥293.89 Million ≈ $43.01 Million |
CN¥13.83 Million ≈ $2.02 Million |
0.047x | -23.99% |
| 2008-12-31 | CN¥281.68 Million ≈ $41.22 Million |
CN¥17.44 Million ≈ $2.55 Million |
0.062x | +108.09% |
| 2007-12-31 | CN¥269.97 Million ≈ $39.51 Million |
CN¥8.03 Million ≈ $1.18 Million |
0.030x | -23.97% |
| 2006-12-31 | CN¥259.20 Million ≈ $37.93 Million |
CN¥10.14 Million ≈ $1.48 Million |
0.039x | +162.08% |
| 2005-12-31 | CN¥255.97 Million ≈ $37.46 Million |
CN¥3.82 Million ≈ $559.35K |
0.015x | +10.21% |
| 2004-12-31 | CN¥250.42 Million ≈ $36.64 Million |
CN¥3.39 Million ≈ $496.50K |
0.014x | +125.29% |
| 2003-12-31 | CN¥246.22 Million ≈ $36.03 Million |
CN¥-13.19 Million ≈ $-1.93 Million |
-0.054x | -123.77% |
| 2002-12-31 | CN¥85.26 Million ≈ $12.48 Million |
CN¥19.22 Million ≈ $2.81 Million |
0.225x | -- |
About Jiangsu Lianhuan Pharmaceutical Co Ltd
Jiangsu Lianhuan Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals, preparations, and active pharmaceutical ingredients (API) products in China and internationally. The company offers clopidogrel bisulfate tablets, doxycycline hydrochloride, azithromycin, milrinone, dapoxetine hydrochloride, tadalafil, and betasine besylate tablets, as well as aprili… Read more